CARDLYTICS INC - NOTE 1.000% 9/1

CUSIP: 14161WAB1

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
92.28%
Total 13F principal
$18,994,120
Principal change
-$203,520,776
Total reported market value
$32,308,059
Number of holders
12
Value change
-$9,784,625,573
Number of buys
5
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 14161WAB1?
CUSIP 14161WAB1 identifies 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q1 2024

As of 31 Mar 2024, CARDLYTICS INC - NOTE 1.000% 9/1 was held by 12 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $18,994,120 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, WHITEBOX ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, 683 Capital Management, LLC, Verition Fund Management LLC, DeepCurrents Investment Group LLC, OAKTREE CAPITAL MANAGEMENT LP, Penn Mutual Asset Management, Russell Investments Group, Ltd., and Context Capital Management, LLC. This page lists 12 institutional bondholders reporting positions for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.